samedan logo
 
 
spacer
home > pmps > Autumn 2008
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Autumn 2008
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. PMPS provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of PMPS.
   
Text
PDF
bullet
Manufacturing
Brian Dougherty of SCM Pharma Ltd suggests that it is time to seek out new ways to capitalise on innovation in the clinical manufacturing sector  
view
download pdf
Felix Nink at Bosch argues that automation and modular design are radically changing how pharmaceutical processing looks at containment  
view
download pdf
Benoоt Verjans of Aseptic Tech introduces closed vial technology: a new methodology for aseptic filling of injectable drugs  
view
download pdf
Kevin Menard at PerkinElmer Life and Analytical Sciences cites hyphenated techniques as the next generation in laboratory advancements for the pharmaceutical industry  
view
download pdf
Getting a potential new drug or product from the research and development stage into use has to be the key commercial consideration for pharmaceutical companies. Mark Perry from Siemens Automation and Drives explains how embracing manufacturing execution systems (MES) can have a real impact in an industry when every day counts towards financial success  
view
download pdf
bullet
Drug Delivery 
Dr Renaud Janssen at Helvoet Pharma examines the use of silicon in the manufacture of pre-filled syringes, and details its importance in the production of a safe, high-quality product  
view
download pdf
François Dessus and Flore Demay at Stelmi discuss how to ensure the highest degree of assurance in the production of rubber stoppers sterilised by gamma irradiation  
view
download pdf
Cedric Marmonier at Rovipharm traces the development of liquid drug administration from the spoon to the syringe, and examines possible future development  
view
download pdf
Paul Kippax of Malvern Instruments and David Morton of Monash University assess the benefits of using dry powder inhalers in order to optimise the delivery of a wide range of medicinal drugs  
view
download pdf
Ed Wynn at ANSYS analyses the impact of computational fluid dynamics on pulmonary drug delivery  
view
download pdf
bullet
Formulations, Ingredients and Excipients
Kevin Maynard at Imprint Pharmaceuticals and Victor Breedveld from the Georgia Institute of Technology discuss particle tracking microrheology  
view
download pdf
Partnerships between pharma and excipient manufacturers can extend drug patents through novel functionalities and formulations; Hans Huttinga at Sheffield Pharma Ingredients investigates  
view
download pdf
bullet
IT and Logistics
Leigh Jordan at Cognex UK Ltd identifies machine vision and coding as essential ingredients of an efficient traceability strategy  
view
download pdf
Chris Stumpf and Phil Kilby at Waters discuss lean process improvements for the GMP laboratory  
view
download pdf
bullet
PACKING, PACKAGING & ANTI-COUNTERFEITING
Benjamin Kepp of Bischof + Klein GmbH discusses how flexible packaging can solve contamination problems across the whole drug development process  
view
download pdf
John Gill at the Royal National Institute for the Blind discusses what can be done by pharmaceutical packagers to help blind and partially sighted people  
view
download pdf
Gerhard Breu at Körber Medipak explains how the bar in patient compliance can be raised through box wallet packaging  
view
download pdf
With pharmaceutical labelling becoming increasingly regulated, manufacturers and packaging companies are looking for a simple and cost-effective solution. Mark Beauchamp at Citizen Systems Europe explains that the latest generation of label printing technology can meet both requirements  
view
download pdf
Paul Stiff at Farnham Castle International Briefing Centre examines the inherent difficulties in recognising international commercial needs in packaging and manufacturing  
view
download pdf
bullet
COOL CHAIN
Geraint Thomas at Laminar Medica explains how the latest temperature-controlled packaging technology is helping pharmaceutical companies meet the growing challenge of shipping temperature-sensitive products  
view
download pdf
Chris Fore at Envirotainer presents strategies to meet transport service provider obligations as defined in Parental Drug Association Technical Report Number 39  
view
download pdf
In the current financial climate, making the correct choice when selecting chillers and air conditioning systems is more important than ever; Steve Warnock of the Coolmation Group explains why the sector should consider Turbocor compressor chillers when reviewing climate control  
view
download pdf
Tony Wright at Exelsius Cold Chain Management Consultancy examines cold chain management, and tells us it is key to securing both patient safety and the quality of pharmaceutical products  
view
download pdf
Tim Jennings of Emball’iso SA talks to PMPS about the expanding cold chain sector of the pharmaceutical industry  
view
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

ACG ‘Makes it Better’

ACG is consolidating its founding values of caring, collaboration and progressiveness in a comprehensive re-brand. As one of the world's leading suppliers of fully integrated solutions to the global pharmaceutical and nutraceutical industry, ACG is taking this opportunity to share the message at the heart of its operation - ‘Make it Better’
More info >>

White Papers

Analysis of Biopharmaceuticals to Conform to ICHQ6B

RSSL

Worldwide, the pharmaceuticals market is anticipated to grow from more than USD 782 billion in 2011 to approach a value of just over USD 971 billion by the end of 2016, registering a CAGR of over 24%. In 2010 the average medicines expenditure per person within the UK was £271, and this is expected to increase with the ageing population. A significant and increasing proportion of these sales are protein-based biotherapeutics or biomolecules. Currently, these account for 19% of the total market, and are growing at twice the rate of traditional small molecule pharmaceuticals. It is predicted that close to 50% of the top 100 pharmaceutical products will be biomolecules by 2016. By far the largest segment of the biopharmaceutical market is the monoclonal antibody (MAb) with an estimated share of 25.6%, which corresponds to USD 51.1 billion.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement